Qube Research & Technologies (QRT)
RCKT icon

Qube Research & Technologies (QRT)’s Rocket Pharmaceuticals RCKT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
+644,869
New +$2.14M ﹤0.01% 2080
2026
Q1 		– Sell
-219,973
Closed -$772K – 4013
2025
Q4 		$772K Sell
219,973
-794,385
-78% -$2.72M ﹤0.01% 2654
2025
Q3 		$3.31M Sell
1,014,358
-533,904
-34% -$1.68M ﹤0.01% 1985
2025
Q2 		$3.79M Buy
1,548,262
+1,352,469
+691% +$6.85M ﹤0.01% 1869
2025
Q1 		$1.31M Buy
+195,793
New +$1.93M ﹤0.01% 2147
2024
Q2 		– Sell
-177,524
Closed -$4.78M – 4557
2024
Q1 		$4.78M Buy
+177,524
New +$5.04M 0.01% 1258
2023
Q4 		– Sell
-126,862
Closed -$2.6M – 4665
2023
Q3 		$2.6M Sell
126,862
-139,994
-52% -$2.54M 0.01% 1247
2023
Q2 		$5.3M Buy
266,856
+168,207
+171% +$3.4M 0.02% 691
2023
Q1 		$1.69M Buy
+98,649
New +$1.93M 0.01% 1080
2022
Q3 		– Sell
-54,935
Closed -$756K – 2928
2022
Q2 		$756K Buy
54,935
+23,590
+75% +$281K 0.01% 1220
2022
Q1 		$497K Buy
31,345
+3,029
+11% +$52.3K ﹤0.01% 1529
2021
Q4 		$618K Buy
+28,316
New +$772K ﹤0.01% 1467
2021
Q2 		– Sell
-13,650
Closed -$606K – 2712
2021
Q1 		$606K Buy
+13,650
New +$749K 0.01% 1068
2020
Q1 		– Sell
-10,826
Closed -$246K – 1562
2019
Q4 		$246K Buy
+10,826
New +$181K 0.01% 1312

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RCKT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 644,869 shares worth $2.21M. The stake represents ﹤0.01% of the portfolio and ranks #2080 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in RCKT as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in RCKT in Q4 2019 and has held it in 14 quarters since. The position peaked at $5.3M in Q2 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 644,869 shares of Rocket Pharmaceuticals worth $2.21M as of Q2 2026.
  • Rocket Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2080 holding.
  • Qube Research & Technologies (QRT) first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
  • Qube Research & Technologies (QRT)'s Rocket Pharmaceuticals position peaked at $5.3M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.